Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1987 Jan;84(1):256–260. doi: 10.1073/pnas.84.1.256

(5Z,13E)-(15S)-9 alpha,11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2): formation and metabolism by human lung and contractile effects on human bronchial smooth muscle.

K Seibert, J R Sheller, L J Roberts 2nd
PMCID: PMC304182  PMID: 3467352

Abstract

Prostaglandin D2 (PGD2) was recently found to be stereospecifically converted to the compound (5Z,13E)-(15S)-9 alpha,11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-PGF2) by a human liver cytosolic NADPH-dependent 11-ketoreductase enzyme. Because PGD2 is a potent bronchoconstrictor and is released into bronchoalveolar lavage fluid after allergen stimulation in patients with allergic asthma, the ability of human lung to metabolize PGD2 to 9 alpha,11 beta-PGF2 and the contractile effects of 9 alpha,11 beta-PGF2 on human bronchial smooth muscle were investigated. The 100,000 X g supernatant of human lung converted PGD2 in the presence of an NADPH-generating system stereospecifically to 9 alpha,11 beta-PGF2 at a rate of 3.46 +/- 0.94 pmol per min per mg of protein. 9 alpha,11 beta-PGF2 was found to contract human bronchial rings in a dose-dependent fashion with a potency virtually identical with that of both PGD2 and PGF2 alpha, known potent bronchial constrictors. PGD2 was found to be a very poor substrate for human lung 15-hydroxyprostaglandin dehydrogenases and to be preferentially metabolized by lung to 9 alpha,11 beta-PGF2. 9 alpha,11 beta-PGF2 was also found to be a very poor substrate for the lung 15-hydroxyprostaglandin dehydrogenases. Thus, once formed, 9 alpha,11 beta-PGF2 would not be expected to be rapidly inactivated in situ by these metabolic enzymes. These results suggest that 9 alpha,11 beta-PGF2 may participate along with other putative mediators in the pulmonary allergic response in humans.

Full text

PDF
256

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  2. Flower R. J., Harvey E. A., Kingston W. P. Inflammatory effects of prostaglandin D2 in rat and human skin. Br J Pharmacol. 1976 Feb;56(2):229–233. doi: 10.1111/j.1476-5381.1976.tb07446.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fuller R. W., Dixon C. M., Dollery C. T., Barnes P. J. Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis. 1986 Feb;133(2):252–254. doi: 10.1164/arrd.1986.133.2.252. [DOI] [PubMed] [Google Scholar]
  4. Hardy C. C., Robinson C., Tattersfield A. E., Holgate S. T. The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med. 1984 Jul 26;311(4):209–213. doi: 10.1056/NEJM198407263110401. [DOI] [PubMed] [Google Scholar]
  5. Lee S. C., Levine L. Prostaglandin metabolism. II. Identification of two 15-hydroxyprostaglandin dehydrogenase types. J Biol Chem. 1975 Jan 25;250(2):548–552. [PubMed] [Google Scholar]
  6. Lewis R. A., Soter N. A., Diamond P. T., Austen K. F., Oates J. A., Roberts L. J., 2nd Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol. 1982 Oct;129(4):1627–1631. [PubMed] [Google Scholar]
  7. Liston T. E., Roberts L. J., 2nd Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer. J Biol Chem. 1985 Oct 25;260(24):13172–13180. [PubMed] [Google Scholar]
  8. Liston T. E., Roberts L. J., 2nd Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6030–6034. doi: 10.1073/pnas.82.18.6030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Murray J. J., Tonnel A. B., Brash A. R., Roberts L. J., 2nd, Gosset P., Workman R., Capron A., Oates J. A. Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med. 1986 Sep 25;315(13):800–804. doi: 10.1056/NEJM198609253151304. [DOI] [PubMed] [Google Scholar]
  10. Pace-Asciak C., Wolfe L. S. N-butylboronate derivatives of the F prostaglandins. Resolution of prostaglandins of the E and F series by gas-liquid chromatography. J Chromatogr. 1971 Mar 24;56(1):129–133. doi: 10.1016/s0021-9673(00)97786-0. [DOI] [PubMed] [Google Scholar]
  11. Powell W. S. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins. 1980 Nov;20(5):947–957. doi: 10.1016/0090-6980(80)90144-6. [DOI] [PubMed] [Google Scholar]
  12. Pugliese G., Spokas E. G., Marcinkiewicz E., Wong P. Y. Hepatic transformation of prostaglandin D2 to a new prostanoid, 9 alpha,11 beta-prostaglandin F2, that inhibits platelet aggregation and constricts blood vessels. J Biol Chem. 1985 Nov 25;260(27):14621–14625. [PubMed] [Google Scholar]
  13. Roberts L. J., 2nd, Lewis R. A., Oates J. A., Austen K. F. Prostaglandin thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells. Biochim Biophys Acta. 1979 Nov 21;575(2):185–192. doi: 10.1016/0005-2760(79)90020-1. [DOI] [PubMed] [Google Scholar]
  14. Roberts L. J., 2nd, Oates J. A. Accurate and efficient method for quantification of urinary histamine by gas chromatography negative ion chemical ionization mass spectrometry. Anal Biochem. 1984 Jan;136(1):258–263. doi: 10.1016/0003-2697(84)90333-6. [DOI] [PubMed] [Google Scholar]
  15. Roberts L. J., 2nd, Sweetman B. J., Lewis R. A., Austen K. F., Oates J. A. Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med. 1980 Dec 11;303(24):1400–1404. doi: 10.1056/NEJM198012113032405. [DOI] [PubMed] [Google Scholar]
  16. Roberts L. J., 2nd, Sweetman B. J. Metabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis. Prostaglandins. 1985 Sep;30(3):383–400. doi: 10.1016/0090-6980(85)90114-5. [DOI] [PubMed] [Google Scholar]
  17. Ruckrich M. F., Schlegel W., Jung A. Prostaglandin endoperoxide analogues and prostaglandid D2 as substrates of human placental 15-hydroxy prostaglandin dehydrogenase. FEBS Lett. 1976 Sep 15;68(1):59–62. doi: 10.1016/0014-5793(76)80404-8. [DOI] [PubMed] [Google Scholar]
  18. Soter N. A., Lewis R. A., Corey E. J., Austen K. F. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J Invest Dermatol. 1983 Feb;80(2):115–119. doi: 10.1111/1523-1747.ep12531738. [DOI] [PubMed] [Google Scholar]
  19. Sun F. F., Armour S. B., Bockstanz V. R., McGuire J. C. Studies on 15-hydroxyprostaglandin dehydrogenase from monkey lung. Adv Prostaglandin Thromboxane Res. 1976;1:163–169. [PubMed] [Google Scholar]
  20. Watanabe K., Iguchi Y., Iguchi S., Arai Y., Hayaishi O., Roberts L. J., 2nd Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1583–1587. doi: 10.1073/pnas.83.6.1583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Watanabe K., Shimizu T., Iguchi S., Wakatsuka H., Hayashi M., Hayaishi O. An NADP-linked prostaglandin D dehydrogenase in swine brain. J Biol Chem. 1980 Mar 10;255(5):1779–1782. [PubMed] [Google Scholar]
  22. Watanabe K., Yoshida R., Shimizu T., Hayaishi O. Enzymatic formation of prostaglandin F2 alpha from prostaglandin H2 and D2. Purification and properties of prostaglandin F synthetase from bovine lung. J Biol Chem. 1985 Jun 10;260(11):7035–7041. [PubMed] [Google Scholar]
  23. Watanabe T., Shimizu T., Narumiya S., Hayaishi O. NADP-linked 15-hydroxyprostaglandin dehydrogenase for prostaglandin D in human blood platelets. Arch Biochem Biophys. 1982 Jun;216(1):372–379. doi: 10.1016/0003-9861(82)90223-5. [DOI] [PubMed] [Google Scholar]
  24. Wong P. Y. Purification and partial characterization of prostaglandin D2 11-keto reductase in rabbit liver. Biochim Biophys Acta. 1981 May 14;659(1):169–178. doi: 10.1016/0005-2744(81)90281-3. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES